Amgen Expands US Biologics Manufacturing with $650 Million Investment
United States: Amgen (NASDAQ: AMGN) has announced a $650 million investment to expand its biologics manufacturing facilities in…
United States: Amgen (NASDAQ: AMGN) has announced a $650 million investment to expand its biologics manufacturing facilities in…